青島銀行(03866.HK)A股配股發行成功
格隆匯1月12日丨青島銀行(03866.HK)公吿,截至A股配股股權登記日(即2022年1月4日)收市,A股股東持股總量為2,746,655,020股A股,截至A股配股認購繳款結束日(即2022年1月11日),有效認購數量為781,754,230股,認購金額為人民幣2,501,613,536.00元,佔A股配股項下可配售A股配股股份總額(即823,996,506股A股配股股份)的94.87%,超過中國證監會《上市公司證券發行管理辦法》中關於「原股東認購股票的數量未達到擬配售數量70%視為發行失敗的限制,故A股配股發行成功。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.